DE69214310D1 - Pranoprofen enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe - Google Patents

Pranoprofen enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe

Info

Publication number
DE69214310D1
DE69214310D1 DE69214310T DE69214310T DE69214310D1 DE 69214310 D1 DE69214310 D1 DE 69214310D1 DE 69214310 T DE69214310 T DE 69214310T DE 69214310 T DE69214310 T DE 69214310T DE 69214310 D1 DE69214310 D1 DE 69214310D1
Authority
DE
Germany
Prior art keywords
drug
pranoprofen
delayed
drug delivery
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69214310T
Other languages
English (en)
Other versions
DE69214310T2 (de
Inventor
Masunari Fushimi
Hideyoshi Kanbe
Shuichi Kasai
Akira Iwasa
Yoichi Sawayanagi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dojin Iyaku Kako Co Ltd
SSP Co Ltd
Original Assignee
Dojin Iyaku Kako Co Ltd
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dojin Iyaku Kako Co Ltd, SSP Co Ltd filed Critical Dojin Iyaku Kako Co Ltd
Application granted granted Critical
Publication of DE69214310D1 publication Critical patent/DE69214310D1/de
Publication of DE69214310T2 publication Critical patent/DE69214310T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
DE69214310T 1991-02-08 1992-02-04 Pranoprofen enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe Expired - Fee Related DE69214310T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3017769A JP2829794B2 (ja) 1991-02-08 1991-02-08 徐放性経口投与型プラノプロフェン製剤

Publications (2)

Publication Number Publication Date
DE69214310D1 true DE69214310D1 (de) 1996-11-14
DE69214310T2 DE69214310T2 (de) 1997-03-06

Family

ID=11952925

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69214310T Expired - Fee Related DE69214310T2 (de) 1991-02-08 1992-02-04 Pranoprofen enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe

Country Status (8)

Country Link
US (1) US5225206A (de)
EP (1) EP0498372B1 (de)
JP (1) JP2829794B2 (de)
KR (1) KR920016097A (de)
CA (1) CA2060493A1 (de)
DE (1) DE69214310T2 (de)
ES (1) ES2095337T3 (de)
TW (1) TW271396B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2860729B2 (ja) * 1992-03-10 1999-02-24 エスエス製薬株式会社 プラノプロフェン懸濁シロップ剤
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US20010003811A1 (en) * 1998-09-23 2001-06-14 Warren Rufus W. Method and system for rendering a view such as an arrangement for creating a lighting pattern
BR0009176A (pt) * 1999-03-24 2001-12-18 Fmc Corp Partìcula granular, forma de dosagem, métodopara preparar uma partìcula granular, misturaseca, e, formulação granular
ITMI991316A1 (it) * 1999-06-14 2000-12-14 Cip Ninety Two 92 S A Composizioni farmaceutiche orali a rilascio modificato di mesalazina
US6866906B2 (en) 2000-01-26 2005-03-15 International Paper Company Cut resistant paper and paper articles and method for making same
PL358427A1 (en) 2000-01-26 2004-08-09 International Paper Company Low density paperboard articles
DK2939696T3 (en) 2001-10-18 2016-05-23 Nektar Therapeutics Polymer Conjugates of Opioid Antagonists
MXPA06004752A (es) * 2003-10-29 2006-07-05 Wyeth Corp Composiciones farmaceuticas de liberacion mantenida que contienen aplindore y sus derivados.
US20060182692A1 (en) 2003-12-16 2006-08-17 Fishburn C S Chemically modified small molecules
CA2758460C (en) * 2003-12-16 2014-09-23 Nektar Therapeutics Methods of preparing monodisperse oligo (ethylene glycol) reagent compositions
US20110097395A1 (en) * 2008-03-08 2011-04-28 Najib Babul Oral Pharmaceutical Compositions of Buprenorphine and Method of Use
WO2024058093A1 (ja) * 2022-09-16 2024-03-21 東和薬品株式会社 時限放出型顆粒およびその用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597115A (ja) * 1982-07-02 1984-01-14 Yoshitomi Pharmaceut Ind Ltd 消炎鎮痛外用剤
US4486436A (en) * 1982-07-22 1984-12-04 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
DE3678644D1 (de) * 1985-08-16 1991-05-16 Procter & Gamble Wirkstoffpartikel mit sowohl kontinuierlicher als auch schneller freisetzung.
IT1200178B (it) * 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
JPS6468317A (en) * 1987-09-08 1989-03-14 Dainippon Pharmaceutical Co Durative preparation
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations
US4971805A (en) * 1987-12-23 1990-11-20 Teysan Pharmaceuticals Co., Ltd. Slow-releasing granules and long acting mixed granules comprising the same
IT1215726B (it) * 1988-01-18 1990-02-22 Alfa Wassermann Spa Formulazioni galeniche a cessione programmata.
JPH0341020A (ja) * 1989-07-10 1991-02-21 Showa Denko Kk 医薬品組成物
US5095037B1 (en) * 1989-12-21 1995-12-19 Nissho Kk Combined anti-inflammatory agent

Also Published As

Publication number Publication date
JP2829794B2 (ja) 1998-12-02
CA2060493A1 (en) 1992-08-09
KR920016097A (ko) 1992-09-24
EP0498372B1 (de) 1996-10-09
DE69214310T2 (de) 1997-03-06
US5225206A (en) 1993-07-06
TW271396B (de) 1996-03-01
EP0498372A1 (de) 1992-08-12
ES2095337T3 (es) 1997-02-16
JPH04257519A (ja) 1992-09-11

Similar Documents

Publication Publication Date Title
DE729751T1 (de) Tramadolhaltiges Arzneimittel mit verzögerter Wirkstoffabgabe
DE3688532D1 (de) Pharmazeutische darreichungsform mit verzoegerter abgabe.
DE69003568D1 (de) Arzneimittel mit verzoegerter freigabe.
DE69224656D1 (de) Arzneimittel
DE69115229T2 (de) Arzneimittel.
DE69113847D1 (de) Injektionsspritze mit angezeigter Dosierung.
DE69211244D1 (de) Spritze mit Zerstäuber
DE69018647T2 (de) Arzneimittel.
DE3782840T2 (de) Arzneimittel mit verzoegerter freigabe.
NO921958L (no) Farmasoeytisk preparat
NO922006L (no) Farmasoeytisk preparat
FI923581A0 (fi) Farmaceutisk kombinationsformation.
NO923859D0 (no) Medikament
DE69214310D1 (de) Pranoprofen enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe
DE69534283D1 (de) Clonidinhaltiges arzneimittel mit verzögerter wirkstoffabgabe
NO940210D0 (no) Lukke for medikamentbroenn
DE69325196D1 (de) Pranoprofen enthaltendes suspendierfähiges Arzneimittel
DE69217020D1 (de) Arzneimittel mit gesteuerter Wirkstoffabgabe
DE69713505T2 (de) Arzneimittel enthaltend mizolastin mit verzögerter wirkstoffabgabe
FI921786A0 (fi) Farmaceutisk foerening.
FI921785A0 (fi) Farmaceutisk foerening.
DE69724435D1 (de) Sufentanilhaltige arzneimittel mit verzögerter wirkstoffabgabe
DE69218461D1 (de) Pharmazeutische mischung mit antineoplastischer wirksamkeit
NO913327D0 (no) Stol.
FR2685870B1 (fr) Medicament anticancereux.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee